SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SRDX - SurModics - Biotech IPO
SRDX 26.95-1.6%3:59 PM EDT
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Lance Bredvold4/1/2025 10:41:50 AM
   of 84
 
Now that the FTC is challenging sale of SRDX and that could be the permanent outcome, price dropped precipitously to below the $30 level where I was buying. My guess back then was that $30 would hold as the gamble on running their own stent business would justify that price eventually and, in fact, after the first precipitous plunge into the $20;s, investors bid the price back up near the $30 level. I am pleased by that guess on my part though scared by the loss of some employees when the decision to sell into private hands was made apparent to them.
I can only hope that we've been able to retain the best and most capable scientists and FDA/CDC negotiators in case our challenge fails. There were a couple other buyers at lower prices when the deal at $43 was agreed to and perhaps management will try to bring one of them in. I don't really understand why they chose to sell though suspect it had to do with the length of time it was taking to break into the market for their devices and needing more capital which we may not be willing to grant. Could SRDX be sunk by debt so large that they never reach breakeven on their approved product? Or is management simply unwilling to gamble on their ability to singlehandedly achieve profitability?

I also wonder about that legal challenge to the acquisition by some investment group out of New York. What might their thinking be?

And the big question for me is should I be taking advantage of the current bounce to slight gain to escape as the US sinks into recession? Years ago I owned CRBard stock and they found the stent business too competitive for their taste. Scary.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News